Sentence examples for bladder with different from inspiring English sources
Intravesical PstS1 significantly prolonged survival of mice and induced systemic immune responses and cellular infiltration of the bladder with different subpopulations of leukocytes.
The aim of this study was to evaluate IAP estimated by bladder pressure, measured with the bladder infused with different volumes of saline at room and body temperatures, in comparison with intra-gastric pressure (IGP).
In the meantime several studies have established also a microbiome in the bladder with many different species.
This study compared bladder pressure measurements with different priming volumes for assessment of IAP in a porcine model of intra-abdominal hypertension (IAH).
Several antimuscarinic agents are approved for the treatment of overactive bladder syndrome, all with different relative affinities for the M2 subtype [ 48].
By changing the cellular level of the response-identified miRNAs in eight bladder cell lines with different cisplatin sensitivity we found that down-regulation of miR-27a, miR296-5p and miR-642 generally reduced the cell viability, whereas up-regulation of miR-138 and miR-886-3p miR-886-3p miR-886-3p of moreduced half of the cell lines.
By changing the cellular level of the treatment-response associated miRNAs in eight bladder cell lines with different cisplatin sensitivity we found that down-regulation of miR-27a, miR296-5p and miR-642 reduced the cell viability, whereas up-regulation of miR-138 and miR-886-3p miR-886-3p miR-886-3p of moreduced half of the cell lines.
Electrospun PCL/PLLA was seeded with different bladder cells individually or in co-culture condition.
The cytolytic effect of Ad5WS1 on four bladder cancer cell lines with different p53 status was examined.
Furthermore, we studied the effect of up- and down regulation of key miRNAs on the cisplatin sensitivity in eight bladder cancer cell lines with different sensitivities to cisplatin.
To better understand the influence of PTEN expression on the efficacy of mTOR inhibitors, we used three human bladder cancer cell lines with different PTEN status.
